
ZEVRA THERAPEUTICS, INC. — Investor Relations & Filings
Zevra Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing therapies for patients with rare diseases. The company focuses on addressing significant unmet medical needs by combining a data-driven scientific approach with a patient-first perspective. Its portfolio includes commercial products such as MIPLYFFA®, an FDA-approved treatment for Niemann-Pick disease type C (NPC), and OLPRUVA®. Zevra Therapeutics also maintains a late-stage clinical pipeline, specializing in advancing promising medicines that face complex clinical and regulatory challenges for conditions with limited or no available treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-06-05 | English | |
| 10-Q - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-05-06 | English | |
| DEF 14A - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-04-20 | English | |
| 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer) | 2026-03-26 | English | |
| 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer) | 2026-03-19 | English | |
| 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-02-10 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 47983630 | 8-K | 2026-06-05 | English | ||
| 42027237 | 10-Q - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-05-06 | English | ||
| 34691421 | DEF 14A - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-04-20 | English | ||
| 33048522 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer) | 2026-03-26 | English | ||
| 32989270 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer) | 2026-03-19 | English | ||
| 32891827 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-02-10 | English | ||
| 32891826 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-02-04 | English | ||
| 32891828 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-02-04 | English | ||
| 29766128 | 4 Filing | 2026-02-02 | English | ||
| 29766101 | 4 Filing | 2026-02-02 | English | ||
| 29766096 | 4 Filing | 2026-02-02 | English | ||
| 29766080 | 4 Filing | 2026-02-02 | English | ||
| 29766031 | 4 Filing | 2026-02-02 | English | ||
| 12217933 | FORM 4 | 2026-01-07 | English | ||
|
2025
1 filing
| |||||
| 12217935 | 8-K | 2025-12-17 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Humanwell Healthcare (Group) Co.,Ltd.
Global pharmaceutical firm specializing in CNS drugs, anest…
|
600079 | CN | Manufacturing |
|
HUMASIS CO., LTD.
Manufactures in-vitro diagnostic (IVD) devices for Point-of…
|
205470 | KR | Manufacturing |
|
Humedix Co., Ltd.
Develops and manufactures hyaluronic acid-based medical dev…
|
200670 | KR | Manufacturing |
|
HUNAN ER-KANG PHARMACEUTICAL CO.,LTD.
Manufactures pharmaceutical excipients, APIs, and plant-bas…
|
300267 | CN | Manufacturing |
|
HUNAN FANGSHENG PHARMACEUTICAL CO.,LTD
Researches and manufactures TCM, chemical drugs, and supple…
|
603998 | CN | Manufacturing |
|
Hunan Hansen Pharmaceutical Co.,Ltd.
Produces chemical drugs and TCM for cardiovascular, digesti…
|
002412 | CN | Manufacturing |
|
Hunan Jingfeng Pharmaceutical Co.,Ltd.
Researches and produces cardiovascular, cerebrovascular, or…
|
000908 | CN | Manufacturing |
|
Hunan Jiudian Pharmaceutical Co.,Ltd
Develops APIs and finished dosage forms, specializing in tr…
|
300705 | CN | Manufacturing |
|
Hunan Nucien Pharmaceutical Co., Ltd.
Develops and manufactures chemical drugs and APIs for diver…
|
688189 | CN | Manufacturing |
|
Hunan Warrant Pharmaceutical Co., Ltd.
Develops chemical APIs and high-end generics specializing i…
|
688799 | CN | Manufacturing |
ZEVRA THERAPEUTICS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32811/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32811 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32811 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32811 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32811}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ZEVRA THERAPEUTICS, INC. (id: 32811)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.